Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.26 +0.06 (+2.50%)
As of: Oct 22, 2026 · 1:23 PM EDT

Rocket Pharmaceuticals (RCKT) EV to EBIT (2017)

Updated

Rocket Pharmaceuticals' (RCKT) EV to EBIT came in at -6.11 for Q3 2017.

Analysis

Rocket Pharmaceuticals (RCKT) EV to EBIT (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.37 Bn 1,134.95 Bn 19.71 Bn
2 Johnson & Johnson 643.27 Bn 563.13 Bn 17.30 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 358.37 Bn 312.75 Bn 12.21 Bn
5 Novartis Ag 301.91 Bn 265.90 Bn 11.24 Bn
6 Astrazeneca 267.33 Bn 241.01 Bn 12.86 Bn
7 Amgen 241.44 Bn 196.84 Bn 7.24 Bn
8 Gilead Sciences 193.00 Bn 167.20 Bn 6.22 Bn
9 Pfizer 171.57 Bn 118.21 Bn 10.94 Bn
10 Rocket Pharmaceuticals 251.64 Mn -32.06 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 -6.11
Jun 30, 2017 -11.60
API Access

Rocket Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=RCKT&period=max&api_key=YOUR_API_KEY